| 000 | 01467 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518074344.0 | ||
| 264 | 0 | _c20210524 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1433-2981 | ||
| 024 | 7 |
_a10.1016/j.clon.2019.11.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReed, N | |
| 245 | 0 | 0 |
_aExpert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. _h[electronic resource] |
| 260 |
_bClinical oncology (Royal College of Radiologists (Great Britain)) _c05 2020 |
||
| 300 |
_ae145-e153 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xetiology |
| 650 | 0 | 4 | _aExpert Testimony |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xadverse effects |
| 650 | 0 | 4 |
_aQuinolines _xadverse effects |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xdrug therapy |
| 700 | 1 | _aGlen, H | |
| 700 | 1 | _aGerrard, G | |
| 700 | 1 | _aGood, J | |
| 700 | 1 | _aLei, M | |
| 700 | 1 | _aLyon, A R | |
| 700 | 1 | _aStrachan, M | |
| 700 | 1 | _aWadsley, J | |
| 700 | 1 | _aNewbold, K | |
| 773 | 0 |
_tClinical oncology (Royal College of Radiologists (Great Britain)) _gvol. 32 _gno. 5 _gp. e145-e153 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clon.2019.11.010 _zAvailable from publisher's website |
| 999 |
_c30426635 _d30426635 |
||